Health
Compounded and Counterfeit Semaglutide: What the FDA Is Warning About
Shortages pushed patients toward compounded semaglutide. The FDA's latest alert shows why that workaround carries real risk.
Aug 5, 2024
Loading
Search
Results
60 stories for“alterations”
FilterAll 60Business 9Health 8Travel 8Nutrition 7Technology 7Latest Trends 5Sports 5Diving 4Fashion 4Design 1Lifestyle 1Recipes 1
Health
Your HbA1c Is an Average of Your Red Blood Cells, Which Is Why It Sometimes Lies
The test everyone treats as the verdict measures sugar stuck to haemoglobin over the life of a red cell. Anything that changes how long those cells live changes the result, and several of those conditions are common across this region.
Jul 13, 2026
Health
Ebola Travel Guidance Returns to the Departure Checklist
Updated traveler attention around Ebola-affected areas underscores a basic rule: monitor official advice, know the symptoms and seek help without stigmatizing whole countries.
Jul 24, 2026
Health
Disabled People Report More Climate Harm, Exposing a Planning Blind Spot
New survey analysis points to greater climate-related health harm among disabled people, strengthening the case for accessible alerts, evacuation and cooling plans.
Jul 24, 2026
Health
Digital Mindfulness at Work Is Moving From Wellness Advice to Management Practice
New research on mindful technology use reframes burnout as a work-design problem involving notifications, norms and control, not just an employee resilience problem.
Jul 24, 2026
Health
West Nile Cases Are Rising in Europe: What Travelers Should Actually Do
WHO says the risk remains low for most people as cases rise in parts of Europe, but bite prevention and awareness of severe symptoms matter.
Jul 31, 2026
Health
A Personalized Gene Therapy Helped Two Boys With Severe Epilepsy
Two individualized antisense treatments reduced the effects of a rare SCN2A disorder. The results are hopeful, but they come from two carefully monitored patients, not a broad trial.
Aug 1, 2026
Health
The First Oral PCSK9 Drug Changes the Cholesterol Treatment Conversation
FDA approval of the first oral PCSK9 inhibitor adds a once-daily option for adults who need greater LDL reduction, but it does not replace individualized cardiovascular care.
Aug 1, 2026
